Sun Pharmaceutical Industries, Inc.
Records under this name other than the patents Sun Pharmaceutical Industries, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 239 patents it holds.
Back to Sun Pharmaceutical Industries, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,776,345 | Gastric retention controlled drug delivery system Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,163,306 | Oral drug delivery system Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,470,367 | Oral drug delivery system Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,439,851 | Gastric retention system Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,865,902 | Deuterated CFTR Potentiators Formerly held In force · High confidence | In force | High confidence | |
| US 9,181,192 | Deuterated CFTR Potentiators Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 9,512,079 | Deuterated CFTR Potentiators Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 8,664,265 | Stable Dosage Forms of Spiro and Dispiro 1,2,4-Trioxolane Antimalarials Term ended Term ended May 18, 2026 · High confidence | Term ended | Term ended May 18, 2026 | High confidence |
| US 9,241,957 | Compositions and methods for reducing photosensitivity associated with photodynamic therapy Term ended Ended no later than Mar 3, 2026 · USPTO record | Term ended | Ended no later than Mar 3, 2026 | USPTO record |
| US 9,849,090 | Pharmaceutical Compositions of Rifaximin Lapsed on the fee record Ended Dec 26, 2025 · High confidence | Lapsed on the fee record | Ended Dec 26, 2025 | High confidence |